The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Hopefully Amte are attending & making more inroads
https://www.benchmarkminerals.com/events/benchmark-week-online-2021/
Had to google it.
What are the two markets?
The London Stock Exchange operates two principal markets in the UK: the Main Market and the AIM market. The Main Market is made up of ‘premium’ and ‘standard’ listing regimes. A premium listing is typically used by large firms looking to benefit from an increased profile and highly liquid market. Indeed, it is only with a premium listing that a company can be eligible for inclusion in the FTSE indexes. To maintain a premium listing, companies must meet the UK’s highest standards of regulation and corporate governance and pay significant costs.
For those who are uninterested or unlikely to benefit from the liquidity and exposure of a premium listing, a standard listing is more likely to be of interest. For a standard listing, firms only have to comply with minimum EU requirements and pay lower fees. It is the standard listing regime that we will be focusing on here. The alternative investment market, or AIM, is the LSE’s exchange for smaller and growing organisations. It has a simplified regulatory environment designed for the needs of small and emerging companies.
What are the differences?
Financial regulation is highly complex and there are hundreds of technical, intricate differences between a standard listing on the Main Market and a listing on the AIM market.
To transfer to the Main Market, an AIM company must:
1. be eligible for listing on the Official List.
2. be eligible to be admitted to the Main Market.
3. produce a prospectus that has been vetted and approved by the FCA.
4. if seeking a premium listing, appoint a sponsor, and.
5. cancel its admission to AIM.
Some good posts today but just shows how under the radar ALL is & unappreciated in today’s sp. Could post any amount of articles about today’s RNS so people are aware but no interest!!???? 47% increase worth millions & gets no reaction. It’s beyond a joke & also shows how laughable Aim is. Don’t understand the stipulations of being in Aim or the main market. Is it that easy to move? Could someone please explain if they know?
Ps. Our day will eventually come holders.
But too many chunky sales popping up also!!
Not huge buys but a lot of buying pressure late yesterday & continued this morning.
Donmac101. You may play it right & fair play if you do but we all know it’s more than just a name change. As How49 says & I’m guessing that timing of the adjusted amount of lithium we actually have will be announced to wet everyone’s appetite.
Risky business being out now around the demerger. Ok if your not so bothered about the Ricca shares but we’ve been saying & waiting so long for a re rate. Once IRR becomes ALL & stands alone as a lithium company it may re rate instantly. What other lithium company at this price looks so good??
After a lot of patience & little information from the company things seem to be finally starting to move. If they have developed & got these ground breaking cells right Amte could be huge as all invested saw early what it could be. They’ve already been working & testing with BMW. If they like what they see it could be a a ground breaker to get a contact with them.
I hope & pray they have a good marketing team. These sp prices look an absolute steal if they can deliver the products. Gla
The chief financial officer desperately needed some money or had a good reason to sell. Offloading 137 thousand shares in total at rock bottom prices compared to what he could of sold at.
Those that bought at 17p as the sp dropped yesterday got an absolute bargain. Sentiment is positive here now & the sp slowly recovering but still absolute miles to go as to what it can & should be. All things are moving in the right direction. We have been under the radar sp wise for far too long but people that know about IRR know what an absolute prospect this is & I expect the sp to creep up with more jumping on board for the free shares leading up to the deadline date of the 23rd November.
After the 23rd will some sell, possibly & we may get a downward trend but once the demerger is done & dusted there’s a good possibility as the Piedmont CEO says that this could & possibly should 3-4 times. In his interview VM has said there’s a lot of good news to come in 2022. The signs are looking good folks. GLA
Apologies, yes wrong way round
Great find by Teddy of the interview with Piedmont’s CEO who gave away a lot more on IRR than we’ve heard from VM in a while & has been said it potentially unbelievable. I’ve mentioned before there’s no way in the world Piedmont are letting the other 50% of the best quality lithium out there go to a competitor. The question is how they’ll play it & much will they pay for it??
Now the demerger cards have been laid out on the table IMO anyone selling now before the 23rd November even the constant big seller has got there head screwed on the wrong way!! Free shares 8 for 1 in another potential outstanding resource is a gift. Another plus is the imminent listing in the US which can only add to the sp with no previous shares to sell. We are surely in for an sp rerate post demerger.
Patience needed here but very disappointing to see the sp at this level. The IPO was 171p so near to no value for anyone holding or selling. Only just over 30m shares in issue which is very little compared to most companies. Company need to step up now & start getting some good contracts onboard with the release of the first phase of product released.
Tesla worth $1trn as investors cheer deal with Hertz which has ordered 100,000 electric vehicles
Will we get an RNS with notice of a US trading start date? With the dual listing & no more shares added it can only send the sp north with no shares at the off to sell at that end. Interesting to see if AIM will be able to manipulate the sp as they can & do with shares also being bought & sold in the US. Hopefully we’ll get a more true & stable sp.